Literature DB >> 10850291

Internal dosimetry in the use of radiopharmaceuticals in therapy--science at a crossroads?

M G Stabin1.   

Abstract

Because of expanding therapeutic applications, radionuclide dosimetry is in a stage of reference "man" based system to systems for "patient-specific dosimetry." Although the challenges for the latter system are substantial, patient-specific radiation dosimetry has greater relevance to treatment planning.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10850291     DOI: 10.1089/cbr.1999.14.81

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  2 in total

1.  Radiotherapy and risks of tumor regrowth or inducing second cancer.

Authors:  Emad Y Moawad
Journal:  Cancer Nanotechnol       Date:  2011-08-18

2.  Accurate dosimetry in 131I radionuclide therapy using patient-specific, 3-dimensional methods for SPECT reconstruction and absorbed dose calculation.

Authors:  Yuni K Dewaraja; Scott J Wilderman; Michael Ljungberg; Kenneth F Koral; Kenneth Zasadny; Mark S Kaminiski
Journal:  J Nucl Med       Date:  2005-05       Impact factor: 10.057

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.